Glucose Oxidase-Instructed Multimodal Synergistic Cancer Therapy

Lian-Hua Fu1,2, Chao Qi1, Yan-Ru Hu1

  • 1Guangdong Key Laboratory for Biomedical Measurements and Ultrasound Imaging, International Cancer Center, Laboratory of Evolutionary Theranostics, School of Biomedical Engineering, Shenzhen University Health Science Center, Shenzhen, 518060, China.

Insights

Glucose oxidase (GOx) shows promise for cancer therapy by altering the tumor microenvironment. Combining GOx with other treatments enhances synergistic effects for multimodal cancer treatment strategies.

Area of Science:

  • Biochemistry
  • Nanomedicine
  • Cancer Therapy

Background:

  • Glucose oxidase (GOx) is biocompatible and biodegradable.
  • GOx catalyzes glucose oxidation, producing gluconic acid and hydrogen peroxide.
  • This process impacts the tumor microenvironment by reducing oxygen and increasing acidity.

Purpose of the Study:

  • To review studies on GOx-instructed multimodal synergistic cancer therapy.
  • To discuss the synergistic mechanisms of GOx-based therapies.
  • To highlight challenges and future prospects for GOx nanomedicines.

Main Methods:

  • Systematic review of representative studies.
  • Analysis of GOx-instructed multimodal synergistic cancer therapy.
  • Discussion of synergistic mechanisms and challenges.

Main Results:

  • GOx triggers tumor hypoxia, acidity, and oxidative stress.
  • These changes facilitate multimodal synergistic cancer therapy.
  • GOx-based nanomedicines offer potential for advanced cancer treatment.

Conclusions:

  • GOx is a promising agent for multimodal cancer therapy.
  • Further development of GOx-based nanomedicines is warranted.
  • GOx-instructed therapies represent a cutting-edge research area.

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.7K
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
4.0K
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
27.3K
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.4K
Glucose Absorption Into the Small Intestine01:26

Glucose Absorption Into the Small Intestine

Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and...
35.5K